Kerry Whitaker

Kerry Whitaker

Company: Biodesix

Job title: Senior Director, Medical Affairs


Increase NSCLC Drug Commercialization Success by Incorporating Biomarker/Diagnostic Solutions into Clinical Trials 10:00 am

Biomarker-informed care can improve patient outcomes, but ~50% of NSCLC of patients currently do not have biomarker results prior to starting first-line treatment Challenges with clinical trial enrollment can delay NSCLC drug commercialization Drug developers that incorporate biomarkers into their oncology clinical trials are known to be 5x more successful at obtaining FDA approval. How…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.